tm logo
TRIPTIMMUNE
REGISTERED

on 23 Jan 2020

Last Applicant/ Owned by

DEBIOPHARM INTERNATIONAL SA

Forum 'Après-demain', Chemin Messidor 5-7 C.P. 5911CH-1002 Lausanne

CH

Serial Number

1864664 filed on 26th Oct 2017

Registration Number

TMA1070644 registered on 23rd Jan 2020

Registration expiry Date

23rd Jan 2030

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

TRIPTIMMUNE

Trademark usage description

préparations pharmaceutiques utilisées dans le traitement du cancer; préparation pharmaceutiques utilisées dans le traitement du cancer de la prostate Read More

Classification Information


Class [005]
Préparations pharmaceutiques utilisées dans le traitement du cancer; Préparation pharmaceutiques utilisées dans le traitement du cancer de la prostate, du mélanome, du cancer des poumons, du cancer des reins, du cancer de la vessie, du cancer des ovaires, du cancer de la tête et du cou, du cancer gastrique, du cancer colorectal, du cancer du sein, du mésothéliome, et du lymphome de Hodgkin.


Classification kind code

11

Mark Details


Serial Number

1864664

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 27th Nov 2019
Registration Pending
Submitted for opposition 191
on 27th Nov 2019
Registration Fee Notice Sent
Submitted for opposition 42
on 04th Sep 2019
Advertised
Submitted for opposition 26
on 16th Aug 2019
Approved
Submitted for opposition 27
on 16th Aug 2019
Approval Notice Sent
Submitted for opposition 22
on 23rd Jan 2019
Search Recorded
Submitted for opposition 20
on 23rd Jan 2019
Examiner's First Report
Submitted for opposition 30
on 26th Oct 2017
Filed
Submitted for opposition 1
on 26th Oct 2017
Created
Submitted for opposition 31
on 26th Oct 2017
Formalized